Abilita Bio is a San Diego-based biotechnology company that is revolutionizing the field of drug discovery by redefining the druggable landscape. Their proprietary EMP technology enables the exploration and optimization of drug candidates by unlocking the full therapeutic potential of membrane protein targets, which were previously considered intractable or undruggable.
With a focus on removing limitations in discovery approaches, Abilita Bio aims to develop transformative options for future patients by targeting medically important membrane protein targets. Their innovative approach has the potential to develop drugs that were once elusive, offering new possibilities for life-saving therapeutics.
Generated from the website